|
|
 |
|
Viewing report
|
|
|
|
ADHD Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., June 2010, Pages: 321
This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and Rest of World. Annual estimates and forecasts are provided for each region for the period of 2006 through 2015. The report profiles 27 companies including many key and niche players such as Eli Lilly & Company, Johnson & Johnson, Janssen-Cilag, Novartis AG, Shire Plc, UCB S.A., Companies with Drugs in Pipeline for ADHD: Abbott Laboratories, Inc., Cortex Pharmaceuticals, Inc., KemPharm, Inc., and NeuroSearch A/S. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Commercial And Pipeline Insight: ADHD - Immature Adult Market Continues To Offer Greatest Commercial Potential
CNS Therapeutics - Global Strategic Business Report
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2012
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, Q4 2010
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, Q1 2011
R&D Trends: Attention-Deficit Hyperactivity Disorder - Growing pipeline indicates a trend towards adjunctive and adult therapy
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2011
|
|
|
|
